Active, not recruitingPhase 3NCT04856644

Evaluation of the Efficacy and Safety of a 4-month Daily Regimen (2HZPM/2HPM) for Treatment of Pulmonary TB

Studying Tuberculosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Kaohsiung Veterans General Hospital.
Principal Investigator
Susan Shin-Jung Lee, M.D., Ph.D.
Kaohsiung Veterans General Hospital.
Intervention
4-month rifapentine-based regimen(drug)
Enrollment
333 target
Eligibility
20 years · All sexes
Timeline
2020 – 2024

Study locations (4)

Collaborators

National Taiwan University · Taipei Veterans General Hospital, Taiwan · Chang Gung Memorial Hospital · Centers for Disease Control, Taiwan

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04856644 on ClinicalTrials.gov

Other trials for Tuberculosis

Additional recruiting or active studies for the same condition.

See all trials for Tuberculosis →

← Back to all trials